See the DrugPatentWatch profile for Advair
What is Advair HFA 230/21?
Advair HFA is an inhaled prescription medicine for asthma and chronic obstructive pulmonary disease (COPD). The “230/21” label refers to the two active ingredients delivered by the inhaler: fluticasone (a corticosteroid) and salmeterol (a long-acting bronchodilator). “HFA” means it uses a hydrofluoroalkane propellant.
What does “230/21” mean for dosing?
The “230” is the fluticasone strength, and “21” corresponds to the salmeterol strength in the combination product. This is a fixed-dose inhaler, so patients typically use it at the prescribed number of inhalations twice daily (unless their clinician gives different instructions).
When is Advair HFA 230/21 used?
It’s used to help control symptoms and reduce asthma flare-ups in people who need maintenance therapy with an inhaled steroid plus a long-acting bronchodilator. For COPD, it may be prescribed to help with ongoing airflow symptoms in appropriate patients.
What side effects do patients ask about?
Common issues patients report with inhaled fluticasone/salmeterol products can include throat irritation or hoarseness, oral yeast infections (thrush), and the potential for bronchodilator-related effects such as shakiness or palpitations. Serious concerns can include asthma worsening or breathing problems that do not improve as expected. If you want, tell me whether you’re asking for side effects specific to asthma or COPD use.
How do patients reduce thrush and hoarseness?
A key self-care step is rinsing the mouth and gargling (then spitting) after each dose. This helps lower the risk of oral corticosteroid side effects like thrush.
Is this product the same as other Advair versions?
No. Advair HFA has different strengths (like 115/21, 230/21, and 45/21), and there are also non-HFA formulations in some markets. The “230/21” strength matters because it changes the delivered fluticasone dose.
Patent/exclusivity and pricing checks (if you’re researching it)
If your goal is to check who makes Advair HFA 230/21, related patents, or exclusivity status, DrugPatentWatch.com is one place to look up filings and timelines: https://www.drugpatentwatch.com/
---
If you meant something specific by “Advair hfa aer 230 21” (for example, “does it still exist,” “what’s the exact dosage schedule,” “is it generic,” or “does it have a patent”), tell me which angle you want and I’ll narrow it down.